Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SECOND AMENDED AND RESTATED COLLABORATION AGREEMENT GENENTECH, INC. AND BIOGEN IDEC INC.Collaboration Agreement • February 4th, 2011 • Biogen Idec Inc. • Biological products, (no disgnostic substances) • California
THIS SECOND AMENDED AND RESTATED COLLABORATION AGREEMENT (this “Agreement) is made effective as of the 18th day of October, 2010 (the “Second Restated Effective Date”) by and between Biogen Idec Inc. (formerly IDEC Pharmaceuticals Corporation), a Delaware corporation having its principal place of business at 133 Boston Post Road, Weston, Massachusetts 02493 (“IDEC”) and GENENTECH, INC., a Delaware corporation having its principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”), each on behalf of itself and its Affiliates. IDEC and Genentech are sometimes referred to herein individually as a “Party” and collectively as the “Parties,” and references to “IDEC” and “Genentech” shall include their respective Affiliates.
